Viewpoints

Calling for Clarity

November 02, 2020

Industry wants clarification on compliance following the end of the Brexit transition period.

Pandemic-fighting Drugs in Shortage, Again

November 02, 2020

Resolving drug shortages starts with identifying the source of the problem.

Viewpoint: Precompetitive Collaboration Drives Pharma Industry Innovation

October 15, 2020

The IQ Consortium marks a decade of impactful innovation of collaboration through a network of pharmaceutical companies driving change for the bio/pharmaceutical industry.

Viewpoint: Digitizing Processes to Align with GMP Requirements

October 02, 2020

The case for migrating from a paper-based quality management system to a digital platform is presented.

The Elephant (or Donkey) in the Room

October 02, 2020

European pharma companies may have a vested interest in the outcome of the US elections.

Leader of the Pack?

September 02, 2020

AstraZeneca has potentially taken poll position in the race to develop a novel coronavirus vaccine, but will AZD1222 be ready in 2020?

Reinvesting in European Manufacturing

August 02, 2020

COVID-19 has brought to light the issues of European manufacturing capabilities, leading industry to question whether it is now time to reinvest in domestic medicines supply.

Dealing a Blow to Biopharma

August 02, 2020

COVID-19’s impact on the global economy is dealing a blow to merger and acquisition activity in the biopharma industry.

Unprecedented Times in Vaccines

July 02, 2020

COVID-19 vaccines are being developed rapidly, giving rise to a reinvigoration of the sector.

No Business, Like Brexit Business

July 02, 2020

As Brexit talks intensify, bio/pharma companies from both the UK and EU need to consider and aim to prepare for all scenarios.